MabSpace Biosciences Co.
Latest round
- Series B
Last raised
- May 2018
Total raised
- $55M
Investors
- 3
About MabSpace Biosciences Co.
, Ltd. is a biotechnology company that focuses on the development of antibody drugs and diagnostic reagents. In 2019, The company was merged with a biopharmaceutical company Transcenta Holding Ltd. The company became subsidiary brand of Transcenta Holding Ltd. The company provides antibody-based therapeutics for the treatment of cancer and fibrotic disorders affecting lung, kidney and liver. The company uses immune tolerance breaking technology (IMBT) in generating antibodies.
Who invested in MabSpace Biosciences Co.
3 investors across 2 rounds
See all investors in MabSpace Biosciences Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about MabSpace Biosciences Co.
Who invested in MabSpace Biosciences Co.?
MabSpace Biosciences Co. has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has MabSpace Biosciences Co. raised?
MabSpace Biosciences Co. has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did MabSpace Biosciences Co. last raise money?
MabSpace Biosciences Co.'s most recent round on record is a Series B, in May 2018.
What does MabSpace Biosciences Co. do?
MabSpace Biosciences Co. is a healthcare company.
Where is MabSpace Biosciences Co. headquartered?
MabSpace Biosciences Co. is headquartered in Suzhou, China.
Which VCs invest in companies like MabSpace Biosciences Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, Hengxu Capital and Riverhead Capital back healthcare companies at MabSpace Biosciences Co.'s stage. Their profiles are linked below.
VCs backing healthcare startups at Series B
Raising like MabSpace Biosciences Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.